| This week's sponsor is Premier Research. | | | Making Rare Cancer Drug Research More Efficient
Developing rare cancer drugs demands expertise in oncology and rare disease, disciplines that don't always mesh. Close attention to trial design and regulation is vital - download our new white paper to learn more. Premier Research. It's what we do. Best. |
Featured Story | | | Wednesday, May 31, 2017 Gemphire’s CEO and president, Mina Sooch, has resigned for “personal reasons” less than a year after helping get its cut-price $30 million IPO off the ground. |
|
|
| This week's sponsor is Sensors Expo & Conference 2017. | | | |
Top Stories Wednesday, May 31, 2017 The CEO of Akari Therapeutics has quit amid a probe into the release of phase 2 data and a related analyst report. An investigative committee ruled that ex-CEO Gur Roshwalb had contravened company policy and found an Akari statement falsely claimed a patient met the primary endpoint in a phase 2 trial. Wednesday, May 31, 2017 Merck Ventures has led a $10.8 million (€9.6 million) investment in Inthera Bioscience. The series A sets the Swiss biotech up to wrap up preclinical development of a lead candidate against cancers associated with human papillomavirus. Wednesday, May 31, 2017 NLS Pharma has posted some positive data for its ADHD candidate mazindol CR, which it hopes will have better luck than it did for obesity and narcolepsy after it was pulled off the market. Wednesday, May 31, 2017 Shanghai-based cancer and gout biotech InventisBio has raised $19 million in a series B financing, just a year after its $11 million series A, with the cash injection being led by OrbiMed Asia Partners and original backer Lilly Asia Ventures. Wednesday, May 31, 2017 Israeli pharma Teva has hit its endpoints in the phase 3 Halo study of fremanezumab in migraines as it looks to send off a BLA to the FDA in the coming months. Wednesday, May 31, 2017 Array claims $31.6 million upfront from Ono for rights to binimetinib and encorafenib in Japan and South Korea, adding to its deal with Pierre Fabre in Europe. Wednesday, May 31, 2017 Chiltern has acquired Japanese CRO Integrated Development Associates (IDA), strengthening its presence in Asia. Wednesday, May 31, 2017 Hyalex Orthopedics raised $16 million in a series A round that will support the development of a synthetic polymer that mimics cartilage, which could lead to an alternative treatment for osteoarthritis. Tuesday, May 30, 2017 Meningococcal group B vaccine Bexsero has been helping drive revenue growth for GlaxoSmithKline, but now, with a European approval, Pfizer’s Trumenba is set to challenge it in that lucrative market. | This week's sponsor is J.P. Morgan Private Bank. | | | How Your Assets Are Structured Can Have Long-Term Implications On Your Wealth
As a founder or executive of a healthcare business, it's crucial your assets are titled properly. J.P. Morgan Private Bank knows how to protect your assets and preserve your wealth. Download this article on asset ownership to learn more. |
| | | China-based bispecific antibodies biotech EpimAb Biotherapeutics and WuXi Biologics have penned a deal to push on with EpimAb’s first candidate, EMB-01, toward IND-filing. Release Japanese pharma Eisai has inked a joint research agreement with the Broad Institute for development of a new antimalarial. Release It's deals galore as MabVax Therapeutics has worked out a sponsored research agreement with Memorial Sloan Kettering Cancer Center for CAR-T therapies using its antibody targeting sequences for a range of solid tumor cancers. Release | |
|
Resources Sponsored by Envigo Performing a sophisticated surgery to create a myocardial infarction model. Join us on June 7th at 11:00 AM EDT. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Sponsored By: HealthCore Gain critical insights into how to design and implement pragmatic trials and generate relevant, high-level real-world evidence. Learn when to conduct PTs, design considerations, ethical regulatory issues — and more. Sponsored By: Veeva Join this global webinar to learn a new approach for demonstrating medical affairs' impact with better metrics - beyond reach and frequency, enabling launch success and better engagement with strategic KOL insights, and increasing your organization's share of voice in the healthcare landscape. Presented By: Covance The ICH GCP E6 guideline has been revised to address the complexities associated with today’s clinical trials, and this concise white paper will help you understand the recent guideline changes. Learn how use of risk-based monitoring can help you comply with the guidelines and achieve efficiency in clinical trial design, implementation and reporting. Sponsored By Reprints Desk Puzzled by Scientific Literature Access? Here is your guide for navigating knowledge management’s twists and turns! If yours is a small- or medium-sized biopharma business, we can help you putting the pieces together. Learn the secrets of top knowledge management experts who will show you how to search, discover, acquire and manage knowledge in new ways. Presented By: Covance The recent evolution of immunotherapies and their potential applications have greatly impacted patients’ options for effective oncology treatments. These advances have been powered in part by the use of biomarkers, companion diagnostics (CDx) and complementary diagnostics. Read the white paper. Sponsored By: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Sponsored By: DocuSign The patients who rely on your scientific leadership are expecting more. Sponsored By: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA 2017 BIO International Convention: The Largest Global Biotech Partnering Event of the Year June 19-22 | San Diego, CA Life Sciences Event of the Year! DIA 2017 Global Annual Meeting FierceBiotech Executive Breakfast- Tackling the Drug Price Problem: A Town Hall Debate June 21, 2017 | San Diego, CA |
